Company Filing History:
Years Active: 2024
Title: Kenneth Luskey: Innovator in Drug Delivery Systems
Introduction
Kenneth Luskey is a notable inventor based in Saratoga, CA (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative approaches that enhance treatment outcomes for patients.
Latest Patents
Kenneth Luskey holds a patent for a method titled "Rapid establishment and/or termination of substantial steady-state drug delivery." This invention focuses on treatment methods for diseases or conditions that provide alternatives to traditional injection treatments. The method aims to improve treatment outcomes, ensure 100% treatment compliance, reduce side effects, and achieve rapid establishment of substantial steady-state drug delivery. The invention typically involves continuous drug delivery from an implanted osmotic delivery device, achieving therapeutic concentrations within about 7 days after implantation and maintaining this delivery for at least 3 months. One specific application of this invention is in the treatment of type 2 diabetes mellitus using incretin mimetics. He has 1 patent to his name.
Career Highlights
Kenneth Luskey is associated with I2O Therapeutics, Inc., where he continues to develop and refine innovative drug delivery technologies. His work is pivotal in advancing treatment methodologies that prioritize patient comfort and compliance.
Collaborations
Kenneth collaborates with Thomas R. Alessi, contributing to the development of cutting-edge therapeutic solutions.
Conclusion
Kenneth Luskey's innovative work in drug delivery systems exemplifies the potential for advancements in medical treatment methodologies. His contributions are paving the way for improved patient care and treatment efficacy.